Fig. 4

Comparison between concordant with discordant molecular surrogate subtypes for A disease-free survival (DFS) and B overall survival (OS) in patients with ipsilateral multifocal primary breast cancer (IMBC) surgically treated at Sahlgrenska University Hospital (Gothenburg, Sweden) between 2012 and 2017. One patient with IMBC was excluded from the analysis since the left-side specimen had concordant subtypes, while the right-side specimen had discordant subtypes between the different foci. This patient had no events